A new antiviral facemask which uses nanotechnology to kill viruses including COVID-19 and influenza has been designed and developed by a Nottingham Trent University scientist.
Instead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university.
The copper, which is embedded into the mask material, has ions that are emitted once in contact with a virus and this then creates an interaction with the virus’s genetic material causing it to die and stop reproducing.
Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).